What are AZTA's recent SEC filings?
Azenta, Inc. issued a press release announcing its financial results for the fiscal quarter and year ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
View full filing details →Azenta acquired all outstanding capital stock of SynPlexity Inc., a DNA assembly technology company, and entered into exclusive licensing and supply agreements with Elegen Corp. to expand its GENEWIZ gene synthesis capabilities. Aggregate capital deployment for the Elegen arrangements is expected to range from approximately $32 million to $71 million.
View full filing details →Azenta's Board approved a restructuring plan within its Multiomics segment to consolidate its North American laboratory network, involving workforce reductions and closure of three lab sites. The company expects pre-tax charges of $11-13 million and annualized cost savings of approximately $11 million.
View full filing details →Azenta, Inc. appointed Dr. Martin D. Madaus as Interim President and CEO effective August 22, 2026, and on September 14, 2026, the Board approved his compensation package including a $600,000 base salary, a $600,000 performance bonus, and $1,200,000 in restricted stock units. Additionally, the company granted retention awards of restricted stock units to four named executive officers totaling $2,500,000.
View full filing details →Azenta, Inc. announced the full repayment of a $35 million vendor loan related to the sale of B Medical Systems, receiving the entire $63 million purchase price in cash.
View full filing details →Azenta, Inc. filed an 8-K form with the SEC on August 24, 2026, but the filing text only contains directory listings and boilerplate SEC website navigation, not the actual event details.
View full filing details →Has AZTA ever done a stock split?
No stock splits are recorded for AZTA.
What is AZTA's share float?
Get Real-Time AZTA Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free